
Uncover the next big thing with 31 elite penny stocks that balance risk and reward.
To own Crane, you need to believe it can turn a history of modest revenue pressure into durable, profitable growth across cyclical end markets. The key short term catalyst is whether the projected 24.5% revenue uplift actually comes through, validating recent guidance and supporting confidence in its portfolio mix. The biggest risk remains exposure to delayed projects and softer capital spending in core industrial customers, and this new revenue outlook does not fully neutralize that concern.
The most relevant recent announcement is Crane’s 2026 outlook, which calls for total sales to rise in the low to mid 20% range, with mid single digit core growth and solid operating leverage. This aligns closely with the latest analyst expectations for a 24.5% revenue increase and helps frame whether the anticipated rebound is driven mainly by acquisitions or healthier underlying demand, an important distinction when you think about how sustainable any improvement really is.
Yet behind the upbeat revenue outlook, investors still need to be aware of how ongoing project delays and cyclical end market exposure could...
Read the full narrative on Crane (it's free!)
Crane's narrative projects $2.9 billion revenue and $468.0 million earnings by 2028.
Uncover how Crane's forecasts yield a $218.78 fair value, a 14% upside to its current price.
While consensus now eyes a 24.5% near term revenue jump, the most bearish analysts were assuming only about US$2.7 billion of sales and US$438.9 million of earnings by 2028, so their more cautious view of Crane’s exposure to decarbonization and automation shifts may either soften or harden as they revisit the story after this new guidance.
Explore 4 other fair value estimates on Crane - why the stock might be worth 40% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com